FTCM
MRTX

First Trust Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

First Trust Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-41,231
Closed -$2.42M – 160
2023
Q4 		$2.42M Buy
+41,231
New +$2.42M 0.19% 100